Ajanta Pharma reports 20% rise in Q3 consolidated net profit

02 Feb 2016 Evaluate

Ajanta Pharma has reported results for third quarter ended December 31, 2015. 

The company has reported 21.99% rise in its net profit at Rs 103.34 crore for the quarter ended December 31, 2015 as compared to Rs 84.71 crore for the same quarter in the previous year. The company’s total income has increased by 15.02% to Rs 424.23 crore for the quarter under review from Rs 368.84 crore for the corresponding quarter of the previous year.  

On the consolidated basis, the company has reported 19.60% rise in its net profit after taxes, minority interest and share of profit / (loss) of associates of Rs 111.30 crore for the quarter ended December 31, 2015 as compared to Rs 93.06 crore for the same quarter in the previous year. Total income of the company has increased by 15.03% at Rs 474.38 crore for quarter under review as compared to Rs 412.39 crore for the quarter ended December 31, 2014.       

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×